BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 21389728)

  • 21. Current pharmacologic management of narcolepsy.
    Scharf MB; Fletcher KA; Jennings SW
    Am Fam Physician; 1988 Jul; 38(1):143-8. PubMed ID: 3293383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy.
    Arnulf I; Mignot E
    Sleep; 2004 Nov; 27(7):1242-3. PubMed ID: 15586777
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical features of childhood narcolepsy. Can cataplexy be foretold?
    Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J
    Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 26. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
    Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narcolepsy--master of disguise: evidence-based recommendations for management.
    Mohsenin V
    Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss in narcolepsy patients treated with sodium oxybate.
    Husain AM; Ristanovic RK; Bogan RK
    Sleep Med; 2009 Jun; 10(6):661-3. PubMed ID: 19014899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S; Quera-Salva MA; Machou M
    J Clin Sleep Med; 2011 Dec; 7(6):667-8. PubMed ID: 22171208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
    J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Narcolepsy].
    Billiard M; Cadilhac J
    Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An interesting case of late age at onset of narcolepsy with cataplexy.
    Krishnamurthy VB; Nallamothu V; Singareddy R
    J Clin Sleep Med; 2014 Feb; 10(2):203-5. PubMed ID: 24533004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of sodium oxybate to treat narcolepsy.
    Mayer G
    Expert Rev Neurother; 2012 May; 12(5):519-29. PubMed ID: 22550980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
    Donjacour CE; Aziz NA; Roelfsema F; Frölich M; Overeem S; Lammers GJ; Pijl H
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1069-75. PubMed ID: 21447786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.